Glucagon like Peptide (GLP)-2 Treatment Improves Liver and Bile Duct Injury in the Mdr2-/- Mouse Model of Sclerosing Cholangitis

被引：0
|
作者：
Menz, Moritz [1 ]
Hinterleitner, Lorenz [1 ]
Koenigshofer, Philipp [1 ]
Halilbasic, Emina [1 ]
Kunczer, Victoria [2 ]
Stojakovic, Tatjana [3 ]
Reiberger, Thomas [2 ]
Fuchs, Claudia Daniela [2 ]
Trauner, Michael H. [2 ]
机构：
[1] Med Univ Vienna, Intemal Med 3, Vienna, Austria
[2] Med Univ Vienna, Dept Internal Med 3, Div Gastroenterol & Hepatol, Vienna, Austria
[3] Med Univ Graz, Clin Inst Med & Chem Lab Diagnost, Graz, Austria
来源：
HEPATOLOGY | 2018年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1453
引用
收藏
页码：831A / 831A
页数：1
相关论文
共 50 条
  • [1] Glucagon like peptide-2 treatment improves liver and bile duct injury in the Mdr2-/- mouse model of sclerosing cholangitis
    Menz, Moritz
    Hinterleitner, Lorenz
    Koenigshofer, Philipp
    Halilbasic, Emina
    Kunczer, Victoria
    Stojakovic, Tatjana
    Reiberger, Thomas
    Fuchs, Claudia
    Trauner, Michael
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E167 - E168
  • [2] Tetrahydroxylated bile acids improve cholestatic liver and bile duct injury in the Mdr2-/- mouse model of sclerosing cholangitis via immunomodulatory effects
    Fuchs, Claudia D.
    Dixon, Emmanuel D.
    Hendrikx, Tim
    Mlitz, Veronika
    Wahlstrom, Annika
    Stahlman, Marcus
    Scharnagl, Hubert
    Stojakovic, Tatjana
    Binder, Christoph J.
    Marschall, Hanns-Ulrich
    Trauner, Michael
    HEPATOLOGY COMMUNICATIONS, 2022, 6 (09) : 2368 - 2378
  • [3] Non-steroidal FXR agonist cilofexor improves cholestatic liver injury in the Mdr2-/- mouse model of sclerosing cholangitis
    Fuchs, Claudia D.
    Sroda, Natalie
    Scharnagl, Hubert
    Gupta, Ruchi
    Minto, Wesley
    Stojakovic, Tatjana
    Liles, John T.
    Budas, Grant
    Hollenback, David
    Trauner, Michael
    JHEP REPORTS, 2023, 5 (11)
  • [4] Inhibition of intestinal bile acid absorption improves cholestatic liver and bile duct injury in a mouse model of sclerosing cholangitis
    Baghdasaryan, Anna
    Fuchs, Claudia D.
    Oesterreicher, Christoph H.
    Lemberger, Ursula J.
    Halilbasic, Emina
    Pahlman, Ingrid
    Graffner, Hans
    Krones, Elisabeth
    Fickert, Peter
    Wahlstrom, Annika
    Stahlman, Marcus
    Paumgartner, Gustav
    Marschall, Hanns-Ulrich
    Trauner, Michael
    JOURNAL OF HEPATOLOGY, 2016, 64 (03) : 674 - 681
  • [5] FGF1 Signaling Modulates Biliary Injury and Liver Fibrosis in the Mdr2-/- Mouse Model of Primary Sclerosing Cholangitis
    O'Brien, April
    Zhou, Tianhao
    White, Tori
    Medford, Abigail
    Chen, Lixian
    Kyritsi, Konstantina
    Wu, Nan
    Childs, Jonathan
    Stiles, Danaleigh
    Ceci, Ludovica
    Chakraborty, Sanjukta
    Ekser, Burcin
    Baiocchi, Leonardo
    Carpino, Guido
    Gaudio, Eugenio
    Wu, Chaodong
    Kennedy, Lindsey
    Francis, Heather
    Alpini, Gianfranco
    Glaser, Shannon
    HEPATOLOGY COMMUNICATIONS, 2022, 6 (07) : 1574 - 1588
  • [6] 4-METHYLUMBELLIFERONE IMPROVES LIVER STIFFNESS, CHOLANGIOCYTE PROLIFERATION AND FIBROSIS IN THE Mdr2-/- MOUSE MODEL OF PRIMARY SCLEROSING CHOLANGITIS (PSC)
    Kunimoto, Koshi
    Fan, Weiguo
    Li, Yuan
    Dehnad, Ali
    Mozes, Gergely
    Wang, Yanan
    Nagy, Nadine
    Bollyky, Paul
    Torok, Natalie J.
    HEPATOLOGY, 2021, 74 : 740A - 741A
  • [7] The gut-liver axis is essential for disease progression in the Mdr2-/- mouse model of primary sclerosing cholangitis
    Liao, L.
    Schneider, K. M.
    Frissen, M.
    Strowig, T.
    Marschall, H. -U.
    Wahlstroem, A.
    Eric, G.
    Mohs, A.
    Jin, P.
    Jung, J.
    Reissing, J.
    Sun, H.
    Elfers, C.
    Bieghs, V.
    Cubero, F. J.
    Trautwein, C.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S6 - S6
  • [8] Mdr2-p-glycoprotein-deficient (Mdr2-/-) mouse - A new model for primary sclerosing cholangitis (PSC)?
    Fickert, P
    Fuchsbichler, A
    Zollner, G
    Stumptner, C
    Weiglein, A
    Zatloukal, K
    Denk, H
    Trauner, M
    HEPATOLOGY, 2001, 34 (04) : 509A - 509A
  • [9] PROLONGED ADMINISTRATION OF MELATONIN AMELIORATES BILIARY AND LIVER PHENOTYPES IN THE FEMALE MDR2-/- MOUSE MODEL OF PRIMARY SCLEROSING CHOLANGITIS
    Wu, Nan
    Ceci, Ludovica
    Kennedy, Lindsey
    Chen, Lixian
    Kyritsi, Konstantina
    Barupala, Nipuni
    Onori, Paolo
    Zhou, Tianhao
    Mancinelli, Romina A.
    Carpino, Guido
    Gaudio, Eugenio
    Wu, Chaodong
    Franchitto, Antonio
    Francis, Heather L.
    Alpini, Gianfranco
    Glaser, Shannon S.
    HEPATOLOGY, 2022, 76 : S1016 - S1016
  • [10] Downregulation of p16 Decreases Biliary Damage and Liver Fibrosis in the Mdr2-/- Mouse Model of Primary Sclerosing Cholangitis
    Kyritsi, Konstantina
    Francis, Heather
    Zhou, Tianhao
    Ceci, Ludovica
    Wu, Nan
    Yang, Zhihong
    Meng, Fanyin
    Chen, Lixian
    Baiocchi, Leonardo
    Kundu, Debjyoti
    Kennedy, Lindsey
    Liangpunsakul, Suthat
    Wu, Chaodong
    Glaser, Shannon
    Alpini, Gianfranco
    GENE EXPRESSION-THE JOURNAL OF LIVER RESEARCH, 2020, 20 (02): : 89 - 103
12345